Beren Therapeutics is a startup based in the United States.
Beren Therapeutics is a startup based in the United States.
Beren Therapeutics is a public benefit corporation focused on developing transformative medicines for rare diseases, including investigational drugs like Adrabetadex for Infantile-Onset Niemann-Pick Disease, Type C.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.